We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A baby laying down.

No Adverse Health Risks From Steroids Used for Pre-Term Birth, Study Finds

A ginger haired woman leaning over the arm of a chair.

Scientists Identify Brain Circuit That Suppresses Appetite During Nausea

Immunotherapy attacking a cancer cell.

Immunotherapy Combination Approved for Non-Muscle Invasive Bladder Cancer

Psilocybin Shows Promise for Treatment-Resistant Depression – But Is It Safe?

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

News

Valeant and AstraZeneca to Partner on Brodalumab

US and EU regulatory submission planned in moderate-to-severe psoriasis in Q4 2015.

AMRI Announces Agreement with Saneca Pharmaceuticals

Significantly expands AMRI'S portfolio of controlled substances.

Eisai Inc. and Purdue Pharma Enter Worldwide Collaboration

Companies to develop lemborexant for the potential treatment of insomnia and explore other future indications.

Bristol-Myers Squibb and Promedior Enters into Agreement

Agreement providing exclusive right to acquire Promedior, Inc. and its novel PRM-151 in development for fibrotic diseases.

NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases

Two-year trial did not produce expected metabolic changes, but influenced other life span markers.

Cellular Contamination Pathway for Heavy Elements Identified

Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.

Resverlogix Presents New Data at the ESC Congress 2015

Company presents new data on RVX-208 "apabetalone" a selective BET inhibitor.

Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial

Daratumumab proved generally safe in patients, even at the highest doses.

Xellia Expands Raleigh, NC Site to Become New North American Headquarters

Company enables the relocation of its North American headquarters from Grayslake, Illinois.

Catalyst Biosciences Completes Merger with Targacept

Newly NASDAQ-listed CBIO focused on development of next-generation and long-acting coagulation factors and novel proteases that target the complement pathway.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter